152754-34-2 Usage
Uses
Used in Pharmaceutical Development:
(S)-3-cyclohexylpropyl 1-(3,3-diMethyl-2-oxopentanoyl)piperidine-2-carboxylate is used as a potential candidate in pharmaceutical development for its possible receptor or enzyme binding capabilities. Its complex structure may offer unique interactions with biological targets, making it a promising compound for the development of new drugs.
Used in Chemical Synthesis:
In the chemical synthesis industry, (S)-3-cyclohexylpropyl 1-(3,3-diMethyl-2-oxopentanoyl)piperidine-2-carboxylate is used as a building block or intermediate in the synthesis of more complex molecules. Its unique functional groups and structural features can be leveraged to create novel compounds with specific properties.
Used in Research and Study:
(S)-3-cyclohexylpropyl 1-(3,3-diMethyl-2-oxopentanoyl)piperidine-2-carboxylate is utilized in research and academic settings to study its properties, potential interactions with biological systems, and its behavior under various conditions. This research can provide valuable insights into the compound's potential applications and help guide future development efforts.
Check Digit Verification of cas no
The CAS Registry Mumber 152754-34-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,7,5 and 4 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 152754-34:
(8*1)+(7*5)+(6*2)+(5*7)+(4*5)+(3*4)+(2*3)+(1*4)=132
132 % 10 = 2
So 152754-34-2 is a valid CAS Registry Number.
152754-34-2Relevant articles and documents
Pipecolic acid derivatives for vision and memory disorders
-
, (2008/06/13)
This invention relates to pharmaceutical compositions and methods for treating a vision disorder, improving vision, treating memory impairment, or enhancing memory performance using pipecolic acid derivatives.
Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP 12
Holt, Dennis A.,Luengo, Juan I.,Yamashita, Dennis S.,Oh, Hye-Ja,Konialian, Arda L.,Yen, Hwa-Kwo,Rozamus, Leonard W.,Brandt, Martin,Bossard, Mary J.,Levy, Mark A.,Eggleston, Drake S.,Liang, Jun,Wayne Schultz,Stout, Thomas J.,Clardy, Jon
, p. 9925 - 9938 (2007/10/02)
The design and synthesis of high-affinity FKBP12 ligands is described. These compounds potently inhibit the cis-trans-peptidylprolyl isomerase (rotamase) activity catalyzed by FKBP12 with inhibition constants (Ki,app) as low as 1 nM, yet they possess remarkable structural simplicity relative to FK506 and rapamycin, from which they are conceptually derived. The atomic structures of three FKBP12-ligand complexes and of one unbound ligand were determined by X-ray crystallography and are compared to the FKBP12-FK506 and FKBP12-rapamycin complexes.
